Page last updated: 2024-10-24

positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria

Definition

Target type: biologicalprocess

Any process that activates or increases the frequency, rate, or extent of biosynthesis of antibacterial peptides active against Gram-positive bacteria. [GOC:mah, PMID:10973475]

Positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria involves a complex network of cellular processes aimed at boosting the production of specific antimicrobial peptides that effectively target and eliminate Gram-positive bacteria. This intricate regulation involves a series of steps, beginning with the activation of transcription factors, which in turn bind to specific DNA sequences within the genes encoding these antibacterial peptides. This binding triggers the transcription of these genes, leading to the synthesis of messenger RNA (mRNA) molecules that carry the genetic blueprint for the antibacterial peptides. Subsequently, the mRNA molecules are translated into proteins, forming the precursor peptides. These precursors often undergo post-translational modifications, such as proteolytic cleavage, to become the mature antibacterial peptides. The biosynthesis of these peptides is tightly regulated to ensure an adequate response to Gram-positive bacterial infection. Several mechanisms contribute to this regulation:

* **Induction by bacterial signals:** Gram-positive bacteria release specific molecules, such as peptidoglycan fragments or lipoteichoic acid, that act as danger signals for the host organism. These signals trigger a cascade of events leading to the activation of transcription factors, ultimately increasing the production of antibacterial peptides.

* **Transcriptional control:** Specific transcription factors play a pivotal role in regulating the expression of genes encoding antibacterial peptides. These factors, such as NF-κB, STATs, and AP-1, are activated in response to bacterial signals and bind to promoter regions of these genes, enhancing their transcription.

* **Post-translational modifications:** The precursor peptides often undergo modifications, such as cleavage by proteases, to generate the mature antibacterial peptides. These modifications can alter their activity and stability, contributing to their effectiveness against Gram-positive bacteria.

* **Feedback mechanisms:** The antibacterial peptides themselves can trigger feedback mechanisms to regulate their own production. Some peptides can activate specific receptors on host cells, leading to the downregulation of their own synthesis, preventing excessive production.

The intricate regulation of antibacterial peptide production is essential for maintaining a delicate balance between host defense and preventing excessive immune responses. This fine-tuned regulation ensures the efficient and effective elimination of Gram-positive bacteria while minimizing potential harm to the host organism.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Nucleotide-binding oligomerization domain-containing protein 2A nucleotide-binding oligomerization domain-containing protein 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9HC29]Homo sapiens (human)

Compounds (12)

CompoundDefinitionClassesRoles
paclitaxelTaxus: Genus of coniferous yew trees or shrubs, several species of which have medicinal uses. Notable is the Pacific yew, Taxus brevifolia, which is used to make the anti-neoplastic drug taxol (PACLITAXEL).taxane diterpenoid;
tetracyclic diterpenoid
antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
docetaxel anhydrousdocetaxel anhydrous : A tetracyclic diterpenoid that is paclitaxel with the N-benzyloxycarbonyl group replaced by N-tert-butoxycarbonyl, and the acetoxy group at position 10 replaced by a hydroxy group.

Docetaxel: A semisynthetic analog of PACLITAXEL used in the treatment of locally advanced or metastatic BREAST NEOPLASMS and NON-SMALL CELL LUNG CANCER.
secondary alpha-hydroxy ketone;
tetracyclic diterpenoid
antimalarial;
antineoplastic agent;
photosensitizing agent
muramyl dipeptideglycopeptideimmunological adjuvant
3-methyl-7-pentyl-8-(2-phenylethylthio)purine-2,6-dioneoxopurine
3-methyl-7-(phenylmethyl)-8-(propan-2-ylthio)purine-2,6-dioneoxopurine
1-(4-methylphenyl)sulfonyl-2-benzimidazolaminesulfonamide
1-(4-chlorophenyl)sulfonyl-2-benzimidazolaminesulfonamide
1-(benzenesulfonyl)-2-benzimidazolaminesulfonamide
1-(4-nitrophenyl)sulfonyl-2-benzimidazolaminesulfonamide
pd 166285
1-(4-methoxyphenyl)sulfonyl-2-benzimidazolaminesulfonamide
5,6-dimethyl-1-(4-methylphenyl)sulfonyl-2-benzimidazolaminesulfonamide